The expression of SHC1 was found to be significantly upregulated in brain and CNS, head and neck, kidney, liver, lung, skin, and prostate tumor samples compared to the normal samples (Figure 1A, p-value = 0.05, fold change = 2). This evidence concerns the gene SHC1 and prostate neoplasm.